Suppr超能文献

相似文献

1
FLT3 functional low-frequency variant rs76428106-C is associated with susceptibility to systemic sclerosis.
Rheumatology (Oxford). 2023 Feb 6;62(SI):SI138-SI142. doi: 10.1093/rheumatology/keac406.
2
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease.
Nature. 2020 Aug;584(7822):619-623. doi: 10.1038/s41586-020-2436-0. Epub 2020 Jun 24.
4
Association of GTF2I, NFKB1, and TYK2 Regional Polymorphisms With Systemic Sclerosis in a Chinese Han Population.
Front Immunol. 2021 Jun 23;12:640083. doi: 10.3389/fimmu.2021.640083. eCollection 2021.
5
Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population.
Ann Rheum Dis. 2010 Nov;69(11):1958-64. doi: 10.1136/ard.2009.127928. Epub 2010 May 28.
6
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis.
Clin Exp Rheumatol. 2022 Oct;40(10):1921-1925. doi: 10.55563/clinexprheumatol/mpgq0y. Epub 2021 Oct 19.
8
Genomic Risk Score impact on susceptibility to systemic sclerosis.
Ann Rheum Dis. 2021 Jan;80(1):118-127. doi: 10.1136/annrheumdis-2020-218558. Epub 2020 Oct 1.

本文引用的文献

1
TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis.
Ann Rheum Dis. 2021 Dec;80(12):1594-1603. doi: 10.1136/annrheumdis-2020-219748. Epub 2021 Jul 20.
2
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease.
Nature. 2020 Aug;584(7822):619-623. doi: 10.1038/s41586-020-2436-0. Epub 2020 Jun 24.
4
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
5
T and B lymphocytes in fibrosis and systemic sclerosis.
Curr Opin Rheumatol. 2019 Nov;31(6):576-581. doi: 10.1097/BOR.0000000000000644.
6
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20.
7
Benefits and limitations of genome-wide association studies.
Nat Rev Genet. 2019 Aug;20(8):467-484. doi: 10.1038/s41576-019-0127-1.
8
FMS-like Tyrosine Kinase 3/FLT3: From Basic Science to Clinical Implications.
Physiol Rev. 2019 Jul 1;99(3):1433-1466. doi: 10.1152/physrev.00029.2018.
9
Genome-wide meta-analysis reveals shared new in systemic seropositive rheumatic diseases.
Ann Rheum Dis. 2019 Mar;78(3):311-319. doi: 10.1136/annrheumdis-2018-214127. Epub 2018 Dec 20.
10
Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances.
Front Immunol. 2018 Jul 23;9:1702. doi: 10.3389/fimmu.2018.01702. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验